Skip to main contentNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Actively recruiting — 1 trial
All recent trials (3 shown)
TerminatedPhase 1/2
NCT01898156Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung Cancer
This Phase 1/2 study is designed to assess the following: safety and tolerability of BIW-8962, Dose Limiting Toxicities (DLTs), Maximum Tolerated Dose (MTD), Re…
South Korea37 participantsStarted 2013-07Updated 2024-04-25 Treatment: BIW-8962
UnknownPhase 1
NCT02637531A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549
This dose-escalation study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of IPI-549 monotherapy and IPI-549 in combination with…
United States219 participantsStarted 2015-12Updated 2022-04-04 Treatment: IPI-549 (eganelisib), Nivolumab